Alena Gros Selected Research

Alena Gros Research Topics

Disease

29	Neoplasms (Cancer) 01/2021 - 09/2006
6	Melanoma (Melanoma, Malignant) 01/2016 - 07/2010
3	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 12/2015 - 09/2013
3	Neoplasm Metastasis (Metastasis) 01/2014 - 06/2009
2	Pancreatic Neoplasms (Pancreatic Cancer) 11/2009 - 06/2009
1	Necrosis 01/2016
1	Penile Neoplasms (Penile Cancer) 10/2015
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2015
1	Anus Neoplasms (Anal Cancer) 10/2015
1	Cholangiocarcinoma 05/2014
1	Stomach Neoplasms (Stomach Cancer) 01/2014
1	Adenocarcinoma 01/2014
1	Carcinoma (Carcinomatosis) 09/2012
1	Thrombocytopenia (Thrombopenia) 09/2012

Drug/Important Bio-Agent (IBA)

6	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2019 - 02/2013
6	AntigensIBA 05/2017 - 05/2014
3	Neoplasm Antigens (Tumor Antigens)IBA 04/2016 - 01/2016
2	VaccinesIBA 01/2019 - 03/2017
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2019 - 12/2015
2	EpitopesIBA 12/2015 - 10/2015
2	CytokinesIBA 01/2015 - 09/2012
2	Proteins (Proteins, Gene)FDA Link 05/2014 - 09/2006
1	Interferon-gamma (Interferon, gamma)IBA 01/2021
1	Bispecific AntibodiesIBA 01/2021
1	Interleukin-12 (IL 12)IBA 12/2019
1	Peptides (Polypeptides)IBA 01/2019
1	RNA (Ribonucleic Acid)IBA 05/2017
1	atezolizumabIBA 03/2017
1	pembrolizumabIBA 03/2017
1	IpilimumabIBA 03/2017
1	NivolumabIBA 03/2017
1	Immune Checkpoint InhibitorsIBA 03/2017
1	Kv1.3 Potassium ChannelIBA 01/2016
1	IonsIBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	PotassiumIBA 01/2016
1	HLA-A Antigens (HLA-A)IBA 10/2015
1	Oncogene Proteins (Oncogene Protein)IBA 10/2015
1	VemurafenibIBA 01/2015
1	MucinsIBA 05/2014
1	Biomarkers (Surrogate Marker)IBA 05/2014
1	Member 9 Tumor Necrosis Factor Receptor SuperfamilyIBA 05/2014
1	Immunoglobulins (Immunoglobulin)IBA 05/2014
1	HLA-C Antigens (HLA-C)IBA 01/2014
1	HLA-B Antigens (HLA-B)IBA 01/2014
1	Interleukin-2 (IL2)IBA 09/2013
1	SuspensionsIBA 10/2012
1	Alanine Transaminase (SGPT)IBA 09/2012
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 09/2012
1	IntegrinsIBA 09/2012
1	Complementary DNA (cDNA)IBA 07/2010
1	Hyaluronoglucosaminidase (Hyaluronidase)FDA Link 07/2010
1	Hyaluronic Acid (Hyaluronan)IBA 07/2010
1	Verapamil (Calan)FDA LinkGeneric 05/2010
1	Thymidine KinaseIBA 11/2009
1	Docetaxel (Taxotere)FDA Link 11/2009
1	arginyl-glycyl-aspartic acidIBA 10/2009
1	Sulfates (Sulfates, Inorganic)IBA 10/2009
1	Heparin (Liquaemin)FDA LinkGeneric 10/2009
1	LigandsIBA 10/2009
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 10/2009
1	Urokinase Plasminogen Activator ReceptorsIBA 06/2009
1	adenovirus associated RNA (VA RNA)IBA 09/2006
1	Messenger RNA (mRNA)IBA 09/2006

Therapy/Procedure

15	Therapeutics 01/2021 - 06/2009
12	Immunotherapy 01/2021 - 01/2014
3	Cell- and Tissue-Based Therapy (Cell Therapy) 01/2021 - 02/2013
1	Aftercare (After-Treatment) 01/2016
1	Drug Therapy (Chemotherapy) 01/2014